This analysis should serve as a solid foundation from which to understand and develop targeted interventions against disuse‐related atrophy and age‐related responsiveness to RET, with potential relevance to other diseases characterized by muscle loss (e.g. muscular dystrophy, cancer, and rheumatoid arthritis). This evidence concerns the gene RET and cancer.